Trials / Recruiting
RecruitingNCT05232279
Effect of Testofen on Erectile Function in an Adult Male Population
Effect of Testofen on Erectile Function in an Adult Male Population - A Double Blind, Randomised Controlled Trial.
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- RDC Clinical Pty Ltd · Industry
- Sex
- Male
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testofen 300mg | Testofen in capsule form - To be taken as a 300mg dosage (2 capsules) once daily for 12 weeks. |
| DRUG | Testofen 600mg | Testofen in capsule form - To be taken as a 600mg dosage (2 capsules) once daily for 12 weeks. |
| DRUG | Placebo comparator | The placebo will consist of maltodextrin and will appear identical to the Testofen capsules. The placebo will be administered as per the active treatment - 2 capsules once daily for 12 weeks. |
Timeline
- Start date
- 2022-04-19
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2022-02-09
- Last updated
- 2025-07-24
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05232279. Inclusion in this directory is not an endorsement.